PAM
BLUE

Paradigm Asset Management’s bluebird bio BLUE Stock Holding History

Paradigm Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-355
Closed -$483K – 423
2017
Q2 		$483K Sell
355
-371
-51% -$448K 0.1% 234
2017
Q1 		$854K Buy
+726
New +$741K 0.16% 142
2016
Q3 		– Sell
-27
Closed -$15.2K – 661
2016
Q2 		$15.2K Sell
27
-378
-93% -$214K ﹤0.01% 748
2016
Q1 		$223K Sell
405
-54
-12% -$33.2K 0.04% 302
2015
Q4 		$382K Sell
459
-1,386
-75% -$1.38M 0.07% 275
2015
Q3 		$2.04M Sell
1,845
-216
-10% -$394K 0.27% 120
2015
Q2 		$4.5M Hold
2,061
– – 0.5% 71
2015
Q1 		$3.22M Buy
+2,061
New +$2.72M 0.36% 87

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Paradigm Asset Management's BLUE Position: Q3 2017 in Review

Paradigm Asset Management sold out of bluebird bio (BLUE) in Q3 2017, closing a stake of 355 shares — an estimated $483K sold.

Paradigm Asset Management first reported a position in BLUE in Q1 2015 and held it in 8 quarters. The position peaked at $4.5M in Q2 2015. 243 funds tracked by Wall St. Rank hold BLUE as of Q3 2017.

  • Paradigm Asset Management reported no remaining bluebird bio position as of Q3 2017 after selling out during the quarter.
  • Paradigm Asset Management sold 355 bluebird bio shares in Q3 2017, an estimated $483K.
  • Paradigm Asset Management first reported a position in bluebird bio in Q1 2015 and held it in 8 quarters.
  • Paradigm Asset Management's bluebird bio position peaked at $4.5M in Q2 2015.
  • 243 funds tracked by Wall St. Rank held bluebird bio as of Q3 2017.

Based on Paradigm Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.